Where does Aptarion Biotech AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aptarion Biotech AG ranks #44,782 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aptarion Biotech AG hold?

Aptarion Biotech AG holds 5 US utility patents granted between 2021 and 2025, spanning 8 technology areas.

What is Aptarion Biotech AG's Innovation Score?

Aptarion Biotech AG has an Innovation Score of 40.9 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Aptarion Biotech AG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Aptarion Biotech AG.

What does claim depth mean for Aptarion Biotech AG's patents?

Aptarion Biotech AG's patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aptarion Biotech AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aptarion Biotech AG

Q: What technology areas does Aptarion Biotech AG focus on?

Aptarion Biotech AG's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aptarion ranks #44,782 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#44,782
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 19.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R44782 · Foreign Corporation #44,782 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
LOWER-Q #44,782/49,997
PHOTO-FINISH AppLand
CPC-NARROW C12N · 8 areas
INNOV-PAR 40.9/100
CLAIMS-RICH 19.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: AppLand Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Aptarion Biotech · this assignee

41
Jawaharlal Nehru… · near

41
MRA Systems · near

41
Proteus Industries · near

41
Sangmyung University… · near

41
3D Lighting… · lowest

7

What this shows Aptarion's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Aptarion's grants concentrate

Aptarion Biotech AG is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Aptarion sits between AppLand Inc. and Aquedeon Medical, Inc..

Aptarion's three-year grant acceleration

Aptarion Biotech AG shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Appland

5
Applied Cavitation

5
Applied Energetics

5
Applied Thin Films

5
Aqua Star

5
Aquablok

5
Aquamira

5
Aquedeon Medical

5
Aptarion Biotech ◀

5

What this shows Aptarion holds 5 patents at rank #44,909, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aptarion

By rank, the assignees closest to #44,909 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Aptarion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aptarion, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Jawaharlal Nehru Centre FOR Advanced Scientific Research 41 Proteus Industries Inc. 41 Sangmyung University Industry-Academy Cooperation Foundation 41 MRA Systems, LLC 41

Aptarion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Aptarion Biotech AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2022	1	20.0%
2023	1	20.0%
2025partial year	2	40.0%

Which technologies does Aptarion Biotech AG patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C12Y - Enzymes 2

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#44,782

of 49,997 tracked assignees

Innovation Score

40.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Aptarion Biotech AG's patent record in context - here's where to go next.

Aptarion Biotech AG's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #44,782 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aptarion Biotech AG against AppLand Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.